Wuhan Xuqinxuan Biotechnology Co., Ltd.

About Wuhan Xuqinxuan Biotechnology Co., Ltd.

Wuhan Xuqinxuan Biotechnology Co., Ltd. (Xuqinxuan Biology for short) is located in The Guoying Seed Industry Building, Fourth Road, Shendun, East Lake New Technology Development Zone, Wuhan. Xuqinxuan Biology is committed to the research and development, production, sales and export of in vitro diagnostic reagents. There is a hundred thousand clean workshop and strong r & D center. It has a professional team of 12 people, including 2 doctors, 3 masters and 7 undergraduates, and more than 15 years of experience in r&d and quality control. We have obtained CE certification in 53 products, namely, infectious diseases series (such as Influenza A/B virus antigen Detection Kit), female reproductive health and health care (such as Candida albicans test Kit)  , Rheumatism Test kit (e.g. Rheumatoid Factor Test Kit), tumor detection series (such as AFP detection kit), drug test series (such as morphine (MOR) detection reagent ), inflammation detection series (such as whole-process CRP (CRP+hsCRP) detection kit), myocardial detection series (such as cardiac troponin I (cTnI) detection kit), growth and development detection kit (25-hydroxyvitamin D detection kit). We also have obtained ISO13485 authoritative certification of Lloyd's UK. COVID - 19 reagents has passed the China customs inspection and quarantine, and is applying for product registration in Japan, Singapore, Malaysia, to meet the foreign demand for new epidemic detection. The products to be applied in China are further optimized on the basis of first-generation products, with better quality and stability, and able to meet the requirements of COVID-19 testing in China. It is planned to obtain medical device registration certificates for more than 25 products on colloidal gold platform, fluorescence chromatography quantitative platform, magnetic particle chemiluminescence platform and photochemistry platform in 2023, and achieve full coverage of the products in inflammation, myocardial infarction, gastrointestinal tract, kidney disease, hepatobiliary diseases, infectious diseases, drug abuse and food safety. The technology of fluorescence quantification POCT platform and magnetic particle chemiluminescence platform has reached the international advanced level. Our company takes quality as the basis and technology as the guidance to develop in vitro diagnostic reagents with market competitiveness, and provide global customers with the most satisfactory service.